Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed director Notes underwriting agrmnt
|
Ayala Pharmaceuticals, Inc. (ADXS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/30/2023 |
3
| aMoon Growth Fund Limited Partnership (10% Owner) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
01/23/2023 |
3
| GOLDBERG MURRAY A (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
01/23/2023 |
3
| Bisker-Leib Vered (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
01/23/2023 |
3
| Spiegel Robert J. (Director) has filed a Form 3 on Ayala Pharmaceuticals, Inc. |
02/16/2021 |
3
| Gitelman Igor (Chief Accounting Officer) has filed a Form 3 on Advaxis, Inc. |
06/08/2018 |
3
| Henderson Molly (Executive Vice President & CFO) has filed a Form 3 on Advaxis, Inc. |
04/25/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/25/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/12/2017 |
3
| LOMBARDO ANTHONY A (Interim CEO) has filed a Form 3 on Advaxis, Inc. |
10/28/2013 |
3
| Mayes, Gregory T. (COO) has filed a Form 3 on Advaxis, Inc. |
05/06/2013 |
3
| PETIT ROBERT (Chief Scientific Officer) has filed a Form 3 on Advaxis, Inc. |
01/07/2013 |
3
| O'Connor Daniel (SVP, Legal & Business Dev Off) has filed a Form 3 on Advaxis, Inc. |
01/12/2010 |
3
| Rosenblum Mark J (CFO) has filed a Form 3 on Advaxis, Inc. |
|
|